EV/EBIT Ratio: 14.95x
Is the EV/EBIT ratio high or low?
The EV/EBIT ratio of 14.95x is 47% below its 5-year average of 28.26x, near the low end of its 5-year range (13.73x–48.77x).
As of Friday, June 26, 2026. 27.33% below its 12-month average of 20.57x.
RMD EV/EBIT Ratio Chart
RMD Average EV/EBIT Ratio Chart
RMD Current vs Average EV/EBIT Ratio Chart
RMD EV/EBIT Ratio Metrics
EV/EBIT RATIO
14.95x
EV/EBIT RATIO AVG TTM
20.57x
EV/EBIT RATIO AVG 3Y
23.07x
EV/EBIT RATIO AVG 5Y
28.24x
EV/EBIT RATIO AVG 10Y
29.21x
EV/EBIT RATIO AVG 15Y
24.97x
EV/EBIT RATIO AVG 20Y
24.55x
CURRENT VS TTM AVG
-27.33%
CURRENT VS 3Y AVG
-35.19%
CURRENT VS 5Y AVG
-47.07%
CURRENT VS 10Y AVG
-48.82%
CURRENT VS 15Y AVG
-40.13%
CURRENT VS 20Y AVG
-39.11%
RMD Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $28.81B | 14.95x | 20.57x | 23.07x | 28.24x |
| Biogen Inc. (BIIB)vs › | $29.82B | 21.49x | 13.68x | 14.87x | 15.76x |
| IQVIA Holdings Inc. (IQV)vs › | $31.12B | 19.86x | 21.06x | 24.12x | 29.78x |
| DexCom, Inc. (DXCM)vs › | $26.49B | 26.41x | 37.62x | 63.92x | 100.99x |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 25.58x | 44.23x | 59.98x | 65.58x |
| Medline Inc. (MDLN)vs › | $31.94B | 20.27x | 21.11x | 21.11x | 21.11x |
| Centene Corp. (CNC)vs › | $31.98B | N/A | 10.37x | 16.91x | 20.65x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 23.92x | 26.02x | 26.23x | 29.11x |
| Zoetis Inc. (ZTS)vs › | $32.62B | 11.24x | 17.46x | 23.80x | 27.17x |
| Waters Corporation (WAT)vs › | $24.57B | 56.01x | 28.67x | 26.95x | 26.42x |
EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for ResMed Inc. (RMD)?
- The EV/EBIT ratio for RMD stock is 14.95x.
- Is ResMed Inc.'s EV/EBIT ratio high or low?
- The EV/EBIT ratio of 14.95x is 47% below its 5-year average of 28.26x, near the low end of its 5-year range (13.73x–48.77x).
- What is the TTM average EV/EBIT ratio for ResMed Inc. (RMD)?
- The TTM average EV/EBIT ratio for RMD stock is 20.57x.
- What is the 3Y average EV/EBIT ratio for ResMed Inc. (RMD)?
- The 3Y average EV/EBIT ratio for RMD stock is 23.07x.
- What is the 5Y average EV/EBIT ratio for ResMed Inc. (RMD)?
- The 5Y average EV/EBIT ratio for RMD stock is 28.24x.
- What is the 10Y average EV/EBIT ratio for ResMed Inc. (RMD)?
- The 10Y average EV/EBIT ratio for RMD stock is 29.21x.
- What is the 15Y average EV/EBIT ratio for ResMed Inc. (RMD)?
- The 15Y average EV/EBIT ratio for RMD stock is 24.97x.
- What is the 20Y average EV/EBIT ratio for ResMed Inc. (RMD)?
- The 20Y average EV/EBIT ratio for RMD stock is 24.55x.
RMD EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-25 | 14.95x |
| 2026-06-24 | 14.79x |
| 2026-06-23 | 14.38x |
| 2026-06-22 | 14.16x |
| 2026-06-18 | 14.18x |
| 2026-06-17 | 14.00x |
| 2026-06-16 | 14.59x |
| 2026-06-15 | 14.50x |
| 2026-06-12 | 14.66x |
| 2026-06-11 | 14.47x |
| 2026-06-10 | 14.56x |
| 2026-06-09 | 14.82x |
| 2026-06-08 | 14.53x |
| 2026-06-05 | 14.75x |
| 2026-06-04 | 14.62x |
| 2026-06-03 | 14.01x |
| 2026-06-02 | 13.73x |
| 2026-06-01 | 14.01x |
| 2026-05-29 | 14.33x |
| 2026-05-28 | 15.32x |
| 2026-05-27 | 15.53x |
| 2026-05-26 | 15.68x |
| 2026-05-22 | 15.68x |
| 2026-05-21 | 15.75x |
| 2026-05-20 | 15.82x |
| 2026-05-19 | 15.66x |
| 2026-05-18 | 15.38x |
| 2026-05-15 | 15.21x |
| 2026-05-14 | 15.25x |
| 2026-05-13 | 15.24x |
| 2026-05-12 | 15.35x |
| 2026-05-11 | 14.96x |
| 2026-05-08 | 15.58x |
| 2026-05-07 | 15.59x |
| 2026-05-06 | 15.81x |
| 2026-05-05 | 15.67x |
| 2026-05-04 | 15.79x |
| 2026-05-01 | 15.45x |
| 2026-04-30 | 16.13x |
| 2026-04-29 | 16.85x |
| 2026-04-28 | 17.27x |
| 2026-04-27 | 17.66x |
| 2026-04-24 | 17.49x |
| 2026-04-23 | 17.46x |
| 2026-04-22 | 17.66x |
| 2026-04-21 | 17.60x |
| 2026-04-20 | 17.99x |
| 2026-04-17 | 18.15x |
| 2026-04-16 | 17.88x |
| 2026-04-15 | 18.21x |
| 2026-04-14 | 18.36x |
| 2026-04-13 | 18.32x |
| 2026-04-10 | 18.21x |
| 2026-04-09 | 18.14x |
| 2026-04-08 | 18.36x |
| 2026-04-07 | 17.99x |
| 2026-04-06 | 17.90x |
| 2026-04-02 | 17.83x |
| 2026-04-01 | 17.73x |
| 2026-03-31 | 17.86x |
| 2026-03-30 | 17.50x |
| 2026-03-27 | 17.54x |
| 2026-03-26 | 17.70x |
| 2026-03-25 | 18.01x |
| 2026-03-24 | 18.16x |
| 2026-03-23 | 18.14x |
| 2026-03-20 | 17.98x |
| 2026-03-19 | 18.10x |
| 2026-03-18 | 18.13x |
| 2026-03-17 | 18.59x |
| 2026-03-16 | 18.35x |
| 2026-03-13 | 18.37x |
| 2026-03-12 | 18.50x |
| 2026-03-11 | 19.12x |
| 2026-03-10 | 19.68x |
| 2026-03-09 | 20.15x |
| 2026-03-06 | 20.15x |
| 2026-03-05 | 20.34x |
| 2026-03-04 | 20.64x |
| 2026-03-03 | 20.58x |
| 2026-03-02 | 20.51x |
| 2026-02-27 | 20.42x |
| 2026-02-26 | 20.48x |
| 2026-02-25 | 20.12x |
| 2026-02-24 | 20.05x |
| 2026-02-23 | 20.78x |
| 2026-02-20 | 20.65x |
| 2026-02-19 | 20.42x |
| 2026-02-18 | 20.63x |
| 2026-02-17 | 20.38x |
| 2026-02-13 | 20.12x |
| 2026-02-12 | 19.57x |
| 2026-02-11 | 20.69x |
| 2026-02-10 | 21.01x |
| 2026-02-09 | 22.01x |
| 2026-02-06 | 21.66x |
| 2026-02-05 | 21.29x |
| 2026-02-04 | 20.97x |
| 2026-02-03 | 20.03x |
| 2026-02-02 | 20.30x |
| 2026-01-30 | 20.58x |
| 2026-01-29 | 20.53x |
| 2026-01-28 | 21.41x |
| 2026-01-27 | 21.23x |
| 2026-01-26 | 21.22x |
| 2026-01-23 | 20.96x |
| 2026-01-22 | 21.21x |
| 2026-01-21 | 21.54x |
| 2026-01-20 | 21.03x |
| 2026-01-16 | 21.40x |
| 2026-01-15 | 21.66x |
| 2026-01-14 | 21.56x |
| 2026-01-13 | 21.16x |
| 2026-01-12 | 21.42x |
| 2026-01-09 | 20.97x |
| 2026-01-08 | 20.84x |
| 2026-01-07 | 20.61x |
| 2026-01-06 | 20.69x |
| 2026-01-05 | 20.37x |
| 2026-01-02 | 20.32x |
| 2025-12-31 | 19.99x |
| 2025-12-30 | 20.18x |
| 2025-12-29 | 20.16x |
| 2025-12-26 | 20.32x |
| 2025-12-24 | 20.29x |
| 2025-12-23 | 20.31x |
| 2025-12-22 | 20.48x |
| 2025-12-19 | 20.34x |
| 2025-12-18 | 20.13x |
| 2025-12-17 | 20.42x |
| 2025-12-16 | 20.54x |
| 2025-12-15 | 21.02x |
| 2025-12-12 | 20.95x |
| 2025-12-11 | 20.96x |
| 2025-12-10 | 20.89x |
| 2025-12-09 | 20.47x |
| 2025-12-08 | 20.77x |
| 2025-12-05 | 21.31x |
| 2025-12-04 | 20.89x |
| 2025-12-03 | 20.88x |
| 2025-12-02 | 20.83x |
| 2025-12-01 | 20.63x |
| 2025-11-28 | 21.25x |
| 2025-11-26 | 21.19x |
| 2025-11-25 | 21.25x |
| 2025-11-24 | 20.81x |
| 2025-11-21 | 20.83x |
| 2025-11-20 | 20.25x |
| 2025-11-19 | 20.34x |
| 2025-11-18 | 20.44x |
| 2025-11-17 | 20.32x |
| 2025-11-14 | 20.30x |
| 2025-11-13 | 20.94x |
| 2025-11-12 | 21.00x |
| 2025-11-11 | 20.97x |
| 2025-11-10 | 20.77x |
| 2025-11-07 | 20.89x |
| 2025-11-06 | 20.73x |
| 2025-11-05 | 20.36x |
| 2025-11-04 | 20.46x |
| 2025-11-03 | 20.67x |
| 2025-10-31 | 20.50x |
| 2025-10-30 | 20.95x |
| 2025-10-29 | 21.91x |
| 2025-10-28 | 22.17x |
| 2025-10-27 | 22.40x |
| 2025-10-24 | 22.43x |
| 2025-10-23 | 22.93x |
| 2025-10-22 | 23.04x |
| 2025-10-21 | 23.19x |
| 2025-10-20 | 23.47x |
| 2025-10-17 | 23.18x |
| 2025-10-16 | 23.34x |
| 2025-10-15 | 23.32x |
| 2025-10-14 | 23.35x |
| 2025-10-13 | 23.61x |
| 2025-10-10 | 23.52x |
| 2025-10-09 | 24.03x |
| 2025-10-08 | 24.42x |
| 2025-10-07 | 24.50x |
| 2025-10-06 | 24.34x |
| 2025-10-03 | 24.09x |
| 2025-10-02 | 23.92x |
| 2025-10-01 | 23.42x |
| 2025-09-30 | 23.67x |
| 2025-09-29 | 23.44x |
| 2025-09-26 | 23.37x |
| 2025-09-25 | 23.11x |
| 2025-09-24 | 23.71x |
| 2025-09-23 | 23.83x |
| 2025-09-22 | 23.73x |
| 2025-09-19 | 23.62x |
| 2025-09-18 | 23.63x |
| 2025-09-17 | 23.49x |
| 2025-09-16 | 23.57x |
| 2025-09-15 | 23.45x |
| 2025-09-12 | 23.36x |
| 2025-09-11 | 23.75x |
| 2025-09-10 | 23.38x |
| 2025-09-09 | 24.15x |
| 2025-09-08 | 24.17x |
| 2025-09-05 | 23.96x |
| 2025-09-04 | 23.68x |
| 2025-09-03 | 23.27x |
| 2025-09-02 | 23.43x |
| 2025-08-29 | 23.74x |
| 2025-08-28 | 23.81x |
| 2025-08-27 | 24.39x |
| 2025-08-26 | 24.67x |
| 2025-08-25 | 24.72x |
| 2025-08-22 | 25.41x |
| 2025-08-21 | 24.94x |
| 2025-08-20 | 25.01x |
| 2025-08-19 | 24.74x |
| 2025-08-18 | 24.75x |
| 2025-08-15 | 24.64x |
| 2025-08-14 | 24.63x |
| 2025-08-13 | 24.94x |
| 2025-08-12 | 24.50x |
| 2025-08-11 | 24.59x |
| 2025-08-08 | 24.56x |
| 2025-08-07 | 24.23x |
| 2025-08-06 | 25.56x |
| 2025-08-05 | 25.97x |
| 2025-08-04 | 26.56x |
| 2025-08-01 | 25.44x |
| 2025-07-31 | 24.78x |
| 2025-07-30 | 25.28x |
| 2025-07-29 | 25.30x |
| 2025-07-28 | 24.92x |
| 2025-07-25 | 25.07x |
| 2025-07-24 | 24.92x |
| 2025-07-23 | 24.91x |
| 2025-07-22 | 24.36x |
| 2025-07-21 | 23.78x |
| 2025-07-18 | 23.50x |
| 2025-07-17 | 23.36x |
| 2025-07-16 | 23.16x |
| 2025-07-15 | 22.96x |
| 2025-07-14 | 23.15x |
| 2025-07-11 | 23.18x |
| 2025-07-10 | 23.51x |
| 2025-07-09 | 23.32x |
| 2025-07-08 | 23.38x |
| 2025-07-07 | 23.36x |
| 2025-07-03 | 23.41x |
| 2025-07-02 | 23.31x |
| 2025-07-01 | 23.35x |
| 2025-06-30 | 23.50x |
| 2025-06-27 | 23.24x |
| 2025-06-26 | 23.34x |
| 2025-06-25 | 23.50x |
| 2025-06-24 | 23.31x |
| 2025-06-23 | 23.19x |
| 2025-06-20 | 23.11x |
| 2025-06-18 | 22.85x |
| 2025-06-17 | 22.78x |
| 2025-06-16 | 22.93x |
| 2025-06-13 | 22.71x |
| 2025-06-12 | 22.98x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell